Early postoperative enteral nutrition and its impact on postoperative recovery in gastrointestinal tumor surgery

早期术后肠内营养及其对胃肠道肿瘤手术后康复的影响

阅读:1

Abstract

BACKGROUND: Surgeries for gastrointestinal tumors frequently result in considerable postoperative complications, such as surgical site infections (SSIs) and impaired nutritional parameters. This study focuses on the role of Early Postoperative Enteral Nutrition (EPEN) in alleviating these difficulties. METHODS: This retrospective study included 110 patients undergoing gastrointestinal tumor surgery between January 2019 and January 2023. Patients receiving EPEN were allocated to the observation group, while others received conventional care. Nutritional indices (total protein [TP], albumin [ALB], and prealbumin [PA]) were measured at baseline and on postoperative day 14. Baseline inflammatory status, including C-reactive protein (CRP), procalcitonin (PCT), white blood cell (WBC) count, and derived ratios such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII), was also assessed. Clinical outcomes included wound healing time and postoperative complications. RESULTS: EPEN was associated with faster wound healing (10.32 ± 1.32 vs 13.65 ± 0.21 days; P<0.001) and a lower SSI rate (1.82% vs 17.02%; P = 0.015), with no difference in wound bleeding (5.45% vs 9.09%; P = 0.463). At day 14, TP, ALB, and PA were higher in the EPEN group (TP 70.76 ± 4.53 g/L; ALB 39.24 ± 1.87 g/L; PA 297.45 ± 21.32 mg/L; all P<0.001 vs control). Length of stay was similar (7.82 ± 1.21 vs 7.69 ± 1.59 days; P = 0.630). Time to first flatus (33.6 ± 5.8 vs 47.1 ± 7.1 hours; P<0.001), first bowel movement (55.2 ± 6.3 vs 70.5 ± 8.2 hours; P<0.001), and patient satisfaction (8.50 ± 1.10 vs 7.20 ± 1.30; P<0.001) favored EPEN. CONCLUSIONS: In this retrospective study, EPEN might be associated with improvements in nutritional indicators and clinical outcomes, including faster wound healing and reduced surgical site infections in gastrointestinal tumor patients. However, the current data do not provide sufficient evidence to conclusively determine whether the improvements are directly due to EPEN, further prospective, randomized studies are needed to confirm these associations and clarify their causal relationships.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。